Milan, InSilicoTrials has been innovating the healthcare sector for some years now, helping pharmaceutical companies reduce the time and cost of drug development using modeling & simulation. The release of two new products for oncology that have no equals on the market – PCa GnRH
More4 symposiums on Oncology, General Biologics, Immunology and Cardiology at 6th annual BioPharma Asia Convention 2013. Research on Oncology, Cardiology, Immunology and
More[column]A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced
MoreRotterdam, The Netherlands– IMCD Group B.V. announces it has acquired the business of Indchem International, an established player in the
More[column]Novo Nordisk announced a unique partnership to form Team Novo Nordisk, a global sports team with more than 100 cyclists,
MoreSanofi (EURONEXT: SAN and NYSE: SNY) ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM
More[column width=”360px” padding=”20px”]We are in the midst of third quarter earnings reports, and they show with stark detail what the
More[column width=”360px” padding=”20px”]The supercharged race to get new treatments into the lucrative market for treating rheumatoid arthritis (RA) appeared to
More